---
title: "Zendedi: dextroamphetamine sulfate tablets, 30 mg — FDA announcement Jan 25, 2024 | Is It on Recall"
description: "Mislabeled package"
url: https://isitonrecall.com/recall/fdapress-9e3b75f480838189-zendedi-dextroamphetamine-sulfate-tablets-30-mg/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA company announcement

# Zendedi: dextroamphetamine sulfate tablets, 30 mg — FDA announcement Jan 25, 2024

Reported terminated

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Jan 25, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: dextroamphetamine sulfate tablets, 30 mg
- **Reason**: Mislabeled package
- **Classification**: Not supplied
- **Recalling firm**: Azurity Pharmaceuticals, Inc.
- **Quantity**: Not supplied
- **Agency-reported status**: Terminated in FDA listing
- **Source record identifier**: 9e3b75f480838189

[Open the official record](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate)

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | FOR IMMEDIATE RELEASE – January 24, 2024 – Woburn, Massachusetts, Azurity Pharmaceuticals, Inc. is voluntarily recalling one (1) lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level. The product is being recalled due to a report from a pharmacist in Nebraska who opened a bottle of Zenzedi® 30 mg tablets and found tablets of Carbinoxamine Maleate, an antihistamine drug. Upon learning of the incident, the manufacturer opened a product complaint and an investigation followed.; Product \| NDC No. \| Lot No. \| Exp. Date \| Ship Dates to Wholesalers; Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg \| 24338-856-03 \| F230169A \| 2025-06 \| 08/23/2023 – 11/29/2023 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Product tables from the announcement

These identifying details come from the company announcement posted by FDA. Check the current notice for revisions.

**FDA company announcement, table 1**

| Product | NDC No. | Lot No. | Exp. Date | Ship Dates to Wholesalers |
| --- | --- | --- | --- | --- |
| Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg | 24338-856-03 | F230169A | 2025-06 | 08/23/2023 – 11/29/2023 |

Announcement retrieved Oct 1, 2026. [Official announcement](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate).

## Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

## Dates in the source

- **Fda listing date**: Jan 25, 2024
- **Company announcement date**: Jan 24, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product. An adverse event may also be reported to Azurity via email at aereports@azurity.com.

[Read the current instructions](https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/azurity-pharmaceuticals-inc-issues-voluntary-nationwide-recall-zenzedir-dextroamphetamine-sulfate)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [Azurity Pharmaceuticals, Inc. records](https://isitonrecall.com/brand/azurity-pharmaceuticals-inc/)